販売および管理費 変化する 日付
Agenus USD 10.56M 13.04M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celldex Therapeutics USD 7.84M 1.21M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Merck USD 2.85B 215M 2025-12
Northwest Biotherapeutics USD 7.07M 1.06M 2025-09
Pfizer USD 4.08B 894M 2025-12
Plus Therapeutics USD 3.49M 559K 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12